CLCR Calls 2021 Archive

• Welcome
  Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
• Potential Increase in Testing Demand
  Henry Walke, CDC Center for Preparedness and Response (CPR)
• SARS-CoV-2 Variants Update
  John Barnes, CDC Laboratory and Testing Task Force for the COVID-19 Response
• FDA Update
  Tim Stenzel, US Food and Drug Administration (FDA)
• LOINC In Vitro Diagnostic (LIVD) Test Code Mapping Tool
  MariBeth Gagnon, CDC Division of Laboratory Systems (DLS)

• Welcome
  Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
• Resources for Accurate and Reliable COVID-19 Testing at CLIA Certificate of Waiver Sites
  Nancy Anderson, CDC Division of Laboratory Systems
• FDA Update
  Tim Stenzel, U.S. Food and Drug Administration (FDA)
• SARS-CoV-2 Variants Update
  John Barnes, CDC Laboratory and Testing Task Force for the COVID-19 Response

• Welcome
  Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
• Introduction to Laboratory Risk Management (LRM) and Biological Risk Management for Point-of-Care Testing Sites
  Sabrina Debose, CDC Division of Laboratory Systems (DLS)
• Virtual Reality (VR) Laboratory Training Demo
  Joe Rothschild, CDC Division of Laboratory Systems

• Welcome
  Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
• Successful Mitigation of SARS-CoV-2 Transmission at a Residential Secondary School
  Kevin Volpp and Bruce Kraut, University of Pennsylvania
• SARS-CoV-2 Variants Update
  John Barnes, CDC Laboratory and Testing Task Force for the COVID-19 Response

• Welcome
  • Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
• Say Yes to COVID-19 Testing (SYCT) Initiative Overview
  • Matthew McMahon & Rachael Fleurence, National Institutes of Health (NIH)
• COVID-19 Testing and Policy in Utah K–12 Schools
  • William Lanier, Utah Department of Health
• CMS Update
  • Felicidad (Faye) Valcarcel, Centers for Medicare and Medicaid Services (CMS)
• SARS-CoV-2 Variants Update
  • John Barnes, CDC Laboratory and Testing Task Force for the COVID-19 Response

• Welcome
  Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
• Daily Testing vs. Self-Isolation for School Based COVID-19 Contacts
  Bernadette Young, University of Oxford
• “Test to Stay” Studies
  Ebony Thomas, CDC State, Tribal, Local, and Territorial Support Task Force
• CMS Update
  Felicidad Valcarcel, Centers for Medicare and Medicaid Services (CMS)
• FDA Update
  Toby Lowe, U.S. Food and Drug Administration (FDA)

• Welcome
  Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
• SARS-CoV-2 Variants Update
  John Barnes, CDC Laboratory and Testing Task Force for the COVID-19 Response
• Flu Testing Guidance
  Manish Patel, CDC Influenza Division
• FDA Update
  Tim Stenzel, U.S. Food and Drug Administration (FDA)

• Welcome
  Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
• SARS-CoV-2 Variants Update
  John Barnes, CDC Laboratory and Testing Task Force for the COVID-19 Response
• Testing and Diagnostics Workgroup Update
  Dean Winslow, U.S. Department of Health and Human Services (HHS) Testing and Diagnostics Workgroup
• FDA Update
  Tim Stenzel, U.S. Food and Drug Administration (FDA)

• Welcome
  Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
• Use of Cycle Threshold (Ct) Values 
  Brandi Limbago, CDC Laboratory and Testing Task Force for the COVID-19 Response
• SARS-CoV-2 Variants Update
  Jessica Chen, CDC Laboratory and Testing Task Force for the COVID-19 Response
• RADx Update
  Bruce Tromberg, National Institutes of Health (NIH) RADx
• Abbott BinaxNOW and Emerging Variants
  Wilbur Lam, Joshua Levy, Jennifer Frediani, and Anuradha Rao, Emory University

• Welcome
  Nancy Anderson, CDC Division of Laboratory Systems (DLS)
• CDC Influenza SARS-CoV-2 Multiplex Assay
  Brandi Limbago, CDC Laboratory and Testing Task Force for the COVID-19 Response
• Genomic Changes Causing SARS-CoV-2 Detection Partial Failure
  Daniel D. Rhoads, Cleveland Clinic
• FDA Update
  Tim Stenzel, U.S. Food and Drug Administration (FDA)

• Welcome
  Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
• Public Health Laboratory Support of Point-of-Care Testing Sites
  Sanjib Bhattacharyya, City of Milwaukee Health Department
• Over-the-Counter Tests and CLIA
  Amy Zale, Centers for Medicare & Medicaid Services

• Welcome
  Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
• SARS-CoV-2 Variants Update
  Steve Oberste, CDC Laboratory and Testing Task Force for the COVID-19 Response
• National Wastewater Surveillance System
  Amy Kirby, CDC Division of Foodborne, Waterborne, and Environmental Diseases (DFWED)
• Sodium Citrate Tubes Supply Shortage
  Tammy Beckham and Linda Ricci, U.S. Food and Drug Administration (FDA)
• FDA Update
  Tim Stenzel, U.S. Food and Drug Administration (FDA)
• COVID-19 Viral Testing Tool Demo
  Muktha Natrajan, CDC Division of Laboratory Systems

• Welcome
  Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
• Antigen Testing Guidance
  Muktha Natrajan, CDC Division of Laboratory Systems (DLS)
• Biosafety Guidance Update
  Aufra C. Araujo, CDC Division of Laboratory Systems (DLS)
• SARS-CoV-2 Variants Update
  Steve Oberste, CDC Laboratory and Testing Task Force for the COVID-19 Response
• How the Federal Government is Addressing Laboratory Supply Issues
  Steven Santos, HHS Testing and Diagnostics Workgroup
  Matthew Hubbard, HHS Testing and Diagnostics Workgroup
• FDA Update
  Tim Stenzel, U.S. Food and Drug Administration (FDA)

Welcome

• Nancy Anderson, CDC Division of Laboratory Systems (DLS)

Emergence of SARS-CoV-2 Variants and Impact on IVD Testing

• Richard Creager, NIH RADx Variant Task Force

Saliva-Based SARS-CoV-2 Testing Data

• Anne Wyllie, Yale University

FDA Update

Tim Stenzel, U.S. Food and Drug Administration (FDA)

Welcome

• Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)

SARS-CoV-2 Variants Update

• Vivien Dugan, CDC Laboratory and Testing Task Force for the COVID-19 Response

Updates from the CDC Infectious Diseases Pathology Branch

• Julu Bhatnagar, CDC Division of High-Consequence Pathogens and Pathology (DCHPP)

FDA Update

Tim Stenzel, U.S. Food and Drug Administration (FDA)

Welcome 

• Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)

K-12 Testing Guidance

• Greta Massetti, CDC Community Interventions and Critical Populations Task Force for the COVID-19 Response

SARS-CoV-2 Variants Update 

• Vivien Dugan, CDC Laboratory and Testing Task Force for the COVID-19 Response 

CDC Testing Order for Air Passengers 

• Nicky Cohen, CDC Global Migration Task Force for the COVID-19 Response 

• Pam Diaz, CDC Global Migration Task Force for the COVID-19 Response

FDA Update

• • Tim Stenzel, U.S. Food and Drug Administration (FDA) 

Welcome

• Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)

CDC Virtual Reality Laboratory Training Course

• Joe Rothschild, CDC Division of Laboratory Systems (DLS)

Sequencing Efforts of Public Health Laboratories

• Heather Blankenship and Marty Soehnlen, Michigan Department of Health and Human Services

SARS-CoV-2 Variants Update

• Vivien Dugan, CDC Laboratory and Testing Task Foce for the COVID-19 Response

Vaccine Breakthrough Case Investigations

• Leisha Nolen, CDC COVID-19 Response Vaccine Breakthrough Team

FDA Update

• Tim Stenzel, U.S. Food and Drug Administration (FDA)

Welcome

• Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)

What Are the Clinical Laboratory Result Abnormalities in Patients Hospitalized with COVID-19?

• Nadia Ayala-Lopez, Johns Hopkins Medical Institute

COVID-19 Variants and Surveillance

• Chris Elkins, CDC COVID-19 Laboratory and Testing Task Force

CMS Billing Update

• Sarah Harding, Centers for Medicare & Medicaid Services (CMS)

FDA Update

• Tim Stenzel, U.S. Food and Drug Administration (FDA)

Welcome

• Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)

OneLab Network Overview

• Senia Wilkins, CDC Division of Laboratory Systems (DLS)

Preliminary Data from BinaxNOW Antigen Testing

• Jessica Prince Guerra, CDC Laboratory and Testing Task Force

Vaccine Effect on Serology Testing

• Natalie Thornburg, CDC Laboratory and Testing Task Force

Surveillance Testing for non-CLIA Pop-up Labs

• Amy Zale, Centers for Medicare & Medicaid Services (CMS)

FDA Update

• Tim Stenzel, U.S. Food and Drug Administration (FDA)